Exclusive

Publication

Byline

Location

US Patent Issued to NATCO PHARMA on Sept. 8 for "Process for the preparation of venetoclax and its polymorphs thereof" (Indian Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,197, issued on Sept. 8, was assigned to NATCO PHARMA Ltd. (Hyderabad, India). "Process for the preparation of venetoclax and its polymorphs... Read More


US Patent Issued to Shanghai Fosun Pharmaceutical Industrial Development on Sept. 8 for "Amide oxazole compound" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,198, issued on Sept. 8, was assigned to Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (Shanghai). "Amide oxazole compound" ... Read More


US Patent Issued to The Cleveland Clinic Foundation on Sept. 8 for "Citron kinase inhibitors" (Ohio Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,199, issued on Sept. 8, was assigned to The Cleveland Clinic Foundation (Cleveland). "Citron kinase inhibitors" was invented by Shaun R. St... Read More


US Patent Issued to ASCLETIS PHARMA (CHINA) on Sept. 8 for "GLP-1R agonist and therapeutic method thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,200, issued on Sept. 8, was assigned to ASCLETIS PHARMA (CHINA) Co. Ltd. (Hong Kong). "GLP-1R agonist and therapeutic method thereof" was i... Read More


US Patent Issued to RECURSION PHARMACEUTICALS on Sept. 8 for "MALT-1 modulators" (British, French Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,201, issued on Sept. 8, was assigned to RECURSION PHARMACEUTICALS INC. (Salt Lake City). "MALT-1 modulators" was invented by Peter Ray (Oxf... Read More


US Patent Issued to Novartis on Sept. 8 for "Compounds and compositions as Sppl2a inhibitors" (Swiss, American Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,202, issued on Sept. 8, was assigned to Novartis AG (Basel, Switzerland). "Compounds and compositions as Sppl2a inhibitors" was invented by... Read More


US Patent Issued to BeOne Medicines | on Sept. 8 for "Degradation of Bruton's tyrosine kinase (BTK) by conjugation of BTK inhibitors with E3 ligase ligand methods of use" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,203, issued on Sept. 8, was assigned to BeOne Medicines | GmbH (Basel, Switzerland). "Degradation of Bruton's tyrosine kinase (BTK) by conj... Read More


US Patent Issued to WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT on Sept. 8 for "TRPC5 inhibitor compounds and intermediate thereof, preparation method therefor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,204, issued on Sept. 8, was assigned to WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT Co. LTD. (Wuhan, China). "TRPC5 inhibitor compounds and... Read More


US Patent Issued to TenaRx on Sept. 8 for "4-alkoxypyrrolo[2,1-f[1,2,4triazines and preparation and uses thereof" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,205, issued on Sept. 8, was assigned to TenaRx Inc. (San Diego). "4-alkoxypyrrolo[2,1-f[1,2,4triazines and preparation and uses thereof" wa... Read More


US Patent Issued to Astellas Pharma on Sept. 8 for "4-aminoquinazoline compound" (Japanese Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,206, issued on Sept. 8, was assigned to Astellas Pharma Inc. (Tokyo). "4-aminoquinazoline compound" was invented by Kenichi Kawaguchi (Toky... Read More